Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Neoplasms 3Motor Activity 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Smoking Cessation 1Smoking 1Skin Neoplasms 1Neurocognitive Disorders 1Multiple Endocrine Neoplasia Type 1 1Leukemia 1Kidney Neoplasms 1Hematologic Neoplasms 1Graft vs Host Disease 1Endometrial Neoplasms 1Depression 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1Chronic Disease 1Breast Carcinoma In Situ 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Health × Clear all
NCT01447199 2020-01-07

The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)

M.D. Anderson Cancer Center

Unknown
2,000 enrolled
DermatologicGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Kidney Neoplasms, Skin Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡